Cargando…

Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways

Background: Fifteen to 25-year-olds are the age group most likely to misuse prescription drugs. Few studies have tested theory-driven models of adolescent risk for prescription drug misuse. Moreover, rarely are distinct pathways to different forms of prescription drug misuse considered. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Sherry H., Chinneck, Annie, Thompson, Kara, Afzali, Mohammad H., Nogueira-Arjona, Raquel, Mahu, Ioan T., Conrod, Patricia J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110923/
https://www.ncbi.nlm.nih.gov/pubmed/33986700
http://dx.doi.org/10.3389/fpsyt.2021.640766
_version_ 1783690394487226368
author Stewart, Sherry H.
Chinneck, Annie
Thompson, Kara
Afzali, Mohammad H.
Nogueira-Arjona, Raquel
Mahu, Ioan T.
Conrod, Patricia J.
author_facet Stewart, Sherry H.
Chinneck, Annie
Thompson, Kara
Afzali, Mohammad H.
Nogueira-Arjona, Raquel
Mahu, Ioan T.
Conrod, Patricia J.
author_sort Stewart, Sherry H.
collection PubMed
description Background: Fifteen to 25-year-olds are the age group most likely to misuse prescription drugs. Few studies have tested theory-driven models of adolescent risk for prescription drug misuse. Moreover, rarely are distinct pathways to different forms of prescription drug misuse considered. Methods: We tested mediational paths from personality to mental health symptoms to prescription drug misuse, informed by etiological models of addiction. We specified pathways from particular personality traits to unique forms of prescription drug misuse via specific mental health symptoms. We used semi-longitudinal data collected across two waves of the Co-Venture Trial. Our sample included students from 31 Canadian high schools tested in Grade 9 (n = 3,024) and again in Grade 10 (n = 2,869; 95% retention). Personality (hopelessness, anxiety sensitivity, impulsivity, sensation seeking) was assessed in Grade 9. Mental health symptoms (depression, anxiety, ADHD, conduct disorder) and prescription drug misuse (opioids, sedatives/tranquilizers, stimulants) were assessed at both time points. Results: Consistent with the negative affect regulation model, hopelessness was specifically associated with opioid misuse via depressive symptoms, and anxiety sensitivity was specifically associated with sedative/tranquilizer misuse via anxiety symptoms. Consistent with positive affect regulation, sensation seeking was directly associated with stimulant misuse. Consistent with the psychological dysregulation model, impulsivity was associated with stimulant misuse via ADHD symptoms. And consistent with the deviance proneness model, impulsivity was also associated with unconstrained (i.e., all three forms of) prescription drug misuse via conduct disorder symptoms. Conclusions: Screening for adolescents high in hopelessness, anxiety sensitivity, sensation seeking, or impulsivity and providing them with personality-matched cognitive-behavioral interventions may be helpful in preventing or mitigating prescription drug misuse. Our results point to the specific mental health symptoms that are important to target in each of these personality-matched interventions.
format Online
Article
Text
id pubmed-8110923
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81109232021-05-12 Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways Stewart, Sherry H. Chinneck, Annie Thompson, Kara Afzali, Mohammad H. Nogueira-Arjona, Raquel Mahu, Ioan T. Conrod, Patricia J. Front Psychiatry Psychiatry Background: Fifteen to 25-year-olds are the age group most likely to misuse prescription drugs. Few studies have tested theory-driven models of adolescent risk for prescription drug misuse. Moreover, rarely are distinct pathways to different forms of prescription drug misuse considered. Methods: We tested mediational paths from personality to mental health symptoms to prescription drug misuse, informed by etiological models of addiction. We specified pathways from particular personality traits to unique forms of prescription drug misuse via specific mental health symptoms. We used semi-longitudinal data collected across two waves of the Co-Venture Trial. Our sample included students from 31 Canadian high schools tested in Grade 9 (n = 3,024) and again in Grade 10 (n = 2,869; 95% retention). Personality (hopelessness, anxiety sensitivity, impulsivity, sensation seeking) was assessed in Grade 9. Mental health symptoms (depression, anxiety, ADHD, conduct disorder) and prescription drug misuse (opioids, sedatives/tranquilizers, stimulants) were assessed at both time points. Results: Consistent with the negative affect regulation model, hopelessness was specifically associated with opioid misuse via depressive symptoms, and anxiety sensitivity was specifically associated with sedative/tranquilizer misuse via anxiety symptoms. Consistent with positive affect regulation, sensation seeking was directly associated with stimulant misuse. Consistent with the psychological dysregulation model, impulsivity was associated with stimulant misuse via ADHD symptoms. And consistent with the deviance proneness model, impulsivity was also associated with unconstrained (i.e., all three forms of) prescription drug misuse via conduct disorder symptoms. Conclusions: Screening for adolescents high in hopelessness, anxiety sensitivity, sensation seeking, or impulsivity and providing them with personality-matched cognitive-behavioral interventions may be helpful in preventing or mitigating prescription drug misuse. Our results point to the specific mental health symptoms that are important to target in each of these personality-matched interventions. Frontiers Media S.A. 2021-04-27 /pmc/articles/PMC8110923/ /pubmed/33986700 http://dx.doi.org/10.3389/fpsyt.2021.640766 Text en Copyright © 2021 Stewart, Chinneck, Thompson, Afzali, Nogueira-Arjona, Mahu and Conrod. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Stewart, Sherry H.
Chinneck, Annie
Thompson, Kara
Afzali, Mohammad H.
Nogueira-Arjona, Raquel
Mahu, Ioan T.
Conrod, Patricia J.
Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
title Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
title_full Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
title_fullStr Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
title_full_unstemmed Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
title_short Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
title_sort personality to prescription drug misuse in adolescents: testing affect regulation, psychological dysregulation, and deviance proneness pathways
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110923/
https://www.ncbi.nlm.nih.gov/pubmed/33986700
http://dx.doi.org/10.3389/fpsyt.2021.640766
work_keys_str_mv AT stewartsherryh personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways
AT chinneckannie personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways
AT thompsonkara personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways
AT afzalimohammadh personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways
AT nogueiraarjonaraquel personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways
AT mahuioant personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways
AT conrodpatriciaj personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways